| http://www.w3.org/ns/prov#value | - Park and Chun eventually filed a Korean patent application on an invention related to the compound's cancer-fighting properties, and also sent their study results and other data to Fang-Yu-Lee (Lee), president of Taiwan-based Yung Shin Pharmaceuticals Industrial Co. (Yung Shin), and to Che-Ming Teng.
|